HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A case of atypical hemolytic uremic syndrome.

Abstract
A 9-year-old boy presented with fever not responding to antibiotic therapy and elevated blood urea and serum creatinine levels. The patient developed microangiopathic hemolytic anemia and thrombocytopenia during the hospital stay. Kidney biopsy confirmed the diagnosis of atypical hemolytic uremic syndrome (HUS). The patient had sufficient urine output, normal blood pressure, and no evidence of peripheral edema during the whole course of his disease. Serum levels of anti-Epstein-Barr virus immunoglobulin M was elevated, indicating the possible role of Epstein-Barr virus infection in inducing atypical HUS in this patient. The patient underwent hemodialysis with dramatic response. He was discharged with normal kidney function after a few days. Kidney function and platelet count were normal 12 months after the initial presentation. This case report shows that atypical hemolytic uremic syndrome could have unusual presentations such as the absence of oliguria, hypertension, and edema, with rapid recovery and good prognosis.
AuthorsMohammad Amin Fallahzadeh, Mohammad Kazem Fallahzadeh, Ali Derakhshan, Eslam Shorafa, Yusof Mojtahedi, Bita Geramizadeh, Mohammad Hossein Fallahzadeh
JournalIranian journal of kidney diseases (Iran J Kidney Dis) Vol. 8 Issue 4 Pg. 341-3 (Jul 2014) ISSN: 1735-8604 [Electronic] Iran
PMID25001143 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Immunoglobulin M
Topics
  • Anemia, Hemolytic (etiology)
  • Atypical Hemolytic Uremic Syndrome (blood, diagnosis, therapy)
  • Child
  • Fever (etiology)
  • Herpesvirus 4, Human (immunology)
  • Humans
  • Immunoglobulin M (blood)
  • Male
  • Renal Dialysis
  • Thrombocytopenia (etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: